Step Into a Journey
of Healing & Wellness

When you enter Nushama, a transformative experience begins. In a beautiful and calming environment, we facilitate safe and effective psychedelic treatments for mental wellness – supported by medically trained professionals with decades of experience.

Our Team & Advisors

Our team includes medical specialists in mood and eating disorders, alcohol use disorders, as well as leading researchers and practitioners in ketamine and other psychedelic therapies.

Dr. Radowitz’s focus is preventive medicine, getting to the underlying source before it manifests as “dis-ease,” a misalignment of mind, body, and spirit, evolving his career as a board-certified internist to psychedelics for mental health.

Dr. Robert Glatter, a board-certified emergency medicine physician, is an associate physician at Nushama Wellness. Dr. Glatter has an extensive background in the administration of ketamine over the past 20 years, having recently served as Chief Medical Officer and Medical Director at another ketamine practice. He also has a background in longevity medicine and is an expert in obesity management and nutrition.

Dr. Mark A Braunstein answers the call to healing, medicine, and innovation through his work as a psychiatrist. Mark is a practicing child, adolescent, and adult psychiatrist. His skill sets are an amalgam of psychodynamic theory, traditional psychopharmacology, wilderness, cannabis, and psychedelic psychiatry. He earned his medical degree in 1997, completed a residency in general psychiatry and a fellowship in child/adolescent psychiatry.

Improvements In Symptoms​

The Results

Standard Antidepressants

30% - 60%

Response Rate​

5% - 15%

Percentage of patients with long-term results

Ketamine Infusion

70% - 90%

Response rate

60% - 80%

Percentage of patients with long-term results

Conditions We Treat with Ketamine

Nushama provides a safe yet powerful psychedelic journey that is well-documented to treat:

Depression

Anxiety/Panic

Post-Traumatic Stress Disorder (PTSD)

Alcohol Use Disorder

Many other trauma-related conditions can also benefit:

Obsessive-Compulsive Disorder (OCD)

Eating Disorders

Suicidal Ideation

Postpartum Depression

Find out more about what we treat and our team will help you find your best options.

Medically supervised psychedelic therapy treatments for sustained relief from depression, anxiety, alcohol use disorders, and trauma-induced mood disorders in a serene and safe environment.

OUR KETAMINE EXPERTS LEAD BY

Dr. Steven Radowitz
Chief Medical Officer

Specialists in Internal Medicine, Psychiatry, and Addiction Care.

Nushama

Why Nushama for Ketamine Therapy

Nushama
Dr. Steven Radowitz, MD

Steven Radowitz, MD

Chief Medical Officer

Dr. Radowitz has a wealth of experience seeing the effects trauma can have on our physical health firsthand. He joined Nushama to oversee and develop treatment modalities, believing psychedelics are the future of mental wellness as current solutions treat symptoms, not underlying issues.

Dr. Radowitz also runs the primary care program at Goldman Sachs and has practiced internal medicine and primary care since 1998. Originally from Montreal, he completed his M.D. at Chicago Medical School. He worked at St. Vincent’s in general medicine and HIV/AIDS units and was Medical Director of the inpatient alcohol and opiate detox and treatment unit.

Dr. Radowitz’s focus is preventive medicine, getting to the underlying source before it manifests as “dis-ease,” a misalignment of mind, body, and spirit. He believes psychedelics are a powerful tool to discover the origin of imbalance. On a spiritual journey with Kabbalah, he also studies meditation and yoga. At Nushama, he leads one of the most experienced teams in psychedelic medicine.

Robert Glatter, MD

Dr. Robert Glatter, a board-certified emergency medicine physician, is an associate physician at Nushama Wellness. Dr. Glatter has an extensive background in the administration of ketamine over the past 20 years, having recently served as Chief Medical Officer and Medical Director at another ketamine practice. He also has a background in longevity medicine and is an expert in obesity management and nutrition.

After practicing Emergency Medicine for over 20 years, Dr. Glatter turned his focus to ketamine’s invaluable use for treatment of PTSD, Depression, and other mood disorders by guiding patients on journeys that are healing and enlightening. Partnering with patients, their psychiatrists and therapists, he and his team at Nushama Wellness design personalized journeys with licensed integration therapists to address individual symptoms. He also works with patients to identify specific intervals for booster infusions to optimize the effects of ketamine after completion of their foundational series of six infusions.

Mark Braunstein, DO

Dr. Mark A Braunstein answers the call to healing, medicine, and innovation through his work as a psychiatrist. Mark is a practicing child, adolescent, and adult psychiatrist. His skill sets are an amalgam of psychodynamic theory, traditional psychopharmacology, wilderness, cannabis, and psychedelic psychiatry. He earned his medical degree in 1997, completed a residency in general psychiatry and a fellowship in child/adolescent psychiatry. After years of on-the-ground psychiatry work, Mark began to see the deficits present in contemporary models of treatment. The psychopharmacologic focus left patients fundamentally unchanged, dependent, and struggling with side effects. In 2002, with this knowledge in tow, Mark relocated to Colorado, intent on expanding his practice to include cannabis & wilderness therapy. Through his concurrent work in both fields, Mark has pioneered the practice of wilderness psychiatry & has kept an eclectic private practice for more than 20 years. He has been involved with psychedelics for more than 30 years and is now seen as a visionary in the space working on safely increasing access and efficacy. He studied ketamine assisted psychotherapy under his mentor Dr. Phil Wolfson and is now blessed to be able to teach alongside him.